Literature DB >> 12381548

Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases.

David J Torpy1, Nancy Mullen, Ioannis Ilias, Lynnette K Nieman.   

Abstract

Cushing's syndrome is associated with hypertension in approximately 80% of cases. Hypertension contributes to the marked increased mortality risk of past or current Cushing's syndrome, largely because of increased cardiovascular risk. Observation of the pathophysiological effect of chronically elevated ACTH and cortisol values in patients with ectopic ACTH secretion complements the available data from acute studies of the effects of ACTH and glucocorticoid infusions in normal volunteers. In a retrospective case review, we identified 58 patients with Cushing's syndrome caused by ectopic ACTH secretion, who were treated at the National Institutes of Health between 1983-1997. The diagnosis of an ectopic ACTH cause was confirmed by inferior petrosal sinus sampling and/or pathologic examination of tumor. The commonest causes were bronchial carcinoid (40%) and thymic carcinoid (10%), but 18 of 58 (31%) patients had an unknown source of ectopic ACTH. Hypertension (systolic blood pressure >140 mmHg and/or diastolic blood pressure >90 mmHg in adults) was noted in 45 of 58 (78%) ectopic Cushing's patients, a prevalence similar to that noted in other endogenous Cushing's syndrome etiologies. Hypertension was severe, deemed to require 3 or more drugs by the treating physicians, in 26 of 58 (45%) patients. Hypokalemia was much more prevalent than in patients with other causes of Cushing's syndrome, affecting 33 of 58 (57%) patients. The range of plasma ACTH (17-1557 pg/mL, normal <60) and 24-hour urine cortisol (UC) excretion (192-1600 mcg/24 hr, normal <90) allowed analysis of the influence of these hormones on blood pressure and plasma potassium. There was a significant relationship between 24-hour UC excretion and the presence of hypokalemia (P = 0.003). Eight of nine patients with a UC >6000 mcg/24 hr had hypokalemia. There was no relation between ACTH level and hypokalemia. In addition, we did not find blood pressure severity to be related to UC excretion or ACTH levels. Urine and plasma cortisol and cortisol metabolite measurements suggest that cortisol may act as a mineralocorticoid when in excess, perhaps by saturating the 11beta-hydroxysteroid-dehydrogenase (11beta-HSD2 enzyme) that inactivates cortisol at the renal tubule. The current data suggest that high cortisol levels may be the principal cause of hypokalemic alkalosis in Cushing's syndrome, rather than inhibition of the 11betaHSD2 enzyme by ACTH or the effects of adrenal steroid biosynthetic intermediaries with mineralococorticoid activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12381548     DOI: 10.1111/j.1749-6632.2002.tb04419.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  37 in total

1.  Kinetics and persistence of cardiovascular and locomotor effects of immobilization stress and influence of ACTH treatment.

Authors:  Esther L Sabban; Nina Schilt; Lidia I Serova; Shreeharsha N Masineni; Charles T Stier
Journal:  Neuroendocrinology       Date:  2008-08-13       Impact factor: 4.914

2.  Recurrent acute-onset Cushing's syndrome 6 years after removal of a thymic neuroendocrine carcinoma: from ectopic ACTH to CRH.

Authors:  Camilla Schalin-Jäntti; Sylvia L Asa; Johanna Arola; Timo Sane
Journal:  Endocr Pathol       Date:  2013-03       Impact factor: 3.943

3.  Cushing's syndrome: all variants, detection, and treatment.

Authors:  Susmeeta T Sharma; Lynnette K Nieman
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

4.  Ectopic ACTH syndrome revealed as severe hypokalemia and persistent hypertension during the perioperative period: a case report.

Authors:  Shun Kishimoto; Kiichi Hirota; Hajime Segawa; Kazuhiko Fukuda
Journal:  J Anesth       Date:  2010-11-04       Impact factor: 2.078

5.  Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density.

Authors:  D Jia; C A O'Brien; S A Stewart; S C Manolagas; R S Weinstein
Journal:  Endocrinology       Date:  2006-08-24       Impact factor: 4.736

6.  Surgical treatment of ectopic adrenocorticotropic hormone syndrome with intra-thoracic tumor.

Authors:  Xiang Zhou; Junbiao Hang; Jiaming Che; Zhongyuan Chen; Weicheng Qiu; Jian Ren; Xiaoqing Yang; Jie Xiang; Hecheng Li
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

Review 7.  Mini-review: pheochromocytomas causing the ectopic ACTH syndrome.

Authors:  Chitrabhanu Ballav; Auditi Naziat; Radu Mihai; Niki Karavitaki; Olaf Ansorge; Ashley B Grossman
Journal:  Endocrine       Date:  2012-03-07       Impact factor: 3.633

8.  Cushing's syndrome due to ectopic adrenocorticotropic hormone production secondary to hepatic carcinoid: diagnosis, treatment, and improved quality of life.

Authors:  Susan G Coe; Winston W Tan; Thomas P Fox
Journal:  J Gen Intern Med       Date:  2008-04-02       Impact factor: 5.128

9.  Hypokalaemia: common but not always benign. Severe, persistent hypokalaemia secondary to ectopic ACTH from a carcinoid tumour.

Authors:  Muhammad Muzaffar Mahmood; Kurien John
Journal:  BMJ Case Rep       Date:  2012-11-14

Review 10.  [Epidemiology and etiology of therapy-resistant hypertension].

Authors:  C Schirpenbach; M Reincke
Journal:  Internist (Berl)       Date:  2009-01       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.